A randomised controlled study to evaluate the effect of Naftidrofuryl in a rat ischaemic skin flap model.
The theoretical benefit of Naftidrofuryl in improving survival of ischaemic skin flaps was tested in a randomised controlled study using oral, intraperitoneal and local administration of the drug in three groups of Wistar rats. The vasodilator Naftidrofuryl was shown to be of no value in preventing distal necrosis in a rat skin flap model which has previously responded to pharmacological manipulation.
Masser
M R
MR
Pinderfields Hospital, Wakefield, Yorkshire.
Moir
G C
GC
D000818:Animals; D004341:Drug Evaluation; D006085:Graft Survival / Q000187:drug effects*; D007511:Ischemia / Q000188:drug therapy*; D008297:Male; D009257:Nafronyl / Q000627:therapeutic use*; D011897:Random Allocation; D051381:Rats; D011919:Rats, Inbred Strains; D012867:Skin / Q000098:blood supply*; D013524:Surgical Flaps / Q000502:physiology*
D009257:Nafronyl